RevOpsis Therapeutics
RevOpsis Therapeutics has directed its efforts towards addressing vision loss. By utilizing their exclusive bispecific Surrobody platform, the company aims to target a diverse range of ocular conditions with potential therapeutic agents. The company was founded in 2022 and is based in Springfield, Illinois, United States.
revopsis.comCompany Details
Founded
- 2022
Employees
- Between 5 - 10 employees
Raised
- $26,195,004
Public
- No
Acquired
- No
CEO
Ramanath Bhandari
Founders
- Ramanath BhandariJeff Olson
Company Collections
These are collections RevOpsis Therapeutics is a part of. Click on the collection name to view similar companies.
RevOpsis Therapeutics' Industries
RevOpsis Therapeutics Headquarters Location
4109 Chandlerwood, IL 62711
Total Amount Raised: $26,195,004
RevOpsis Therapeutics Funding Rounds
Grant
$1,800,000
Grant Investors
National Eye Institute (NEI)Seed
$9,000,000
Grant
$7,500,000
Series Unknown
$7,895,004
Funding info provided by Diffbot.
RevOpsis Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on RevOpsis Therapeutics.